Skip to main content

9 Result(s)

within M. Steins Remove this filter

and

  1. No Access

    Article

    Systemtherapie des nichtkleinzelligen Lungenkarzinoms im metastasierten Stadium

    Eine systemische Behandlung ist in den meisten Erkrankungsstadien ein wichtiger Bestandteil der Therapie des Lungenkarzinoms.

    PD Dr. N. Reinmuth, A. Tufman, M. Steins, M. Reck in Der Onkologe (2014)

  2. No Access

    Chapter

    Erlotinib

    The epidermal growth factor receptor (EGFR) has been implicated in a multiplicity of cancer-related signal transduction pathways such as cellular proliferation, adhesion, migration, neoangiogenesis and apoptos...

    M. Steins, M. Thomas, M. Geißler in Small Molecules in Oncology (2014)

  3. No Access

    Chapter

    Erlotinib

    The epidermal growth factor receptor (EGFR) has been implicated in a multiplicity of cancer-related signal transduction pathways like cellular proliferation, adhesion, migration, neoangiogenesis, and apoptosis...

    M. Steins, M. Thomas, M. Geißler in Small Molecules in Oncology (2010)

  4. No Access

    Article

    Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia

    Neuropilin-1 (NRP-1), a vascular endothelial growth factors and semaphorin receptor functioning as mediator of angiogenesis and neuronal guidance, is expressed by various solid tumors. The importance of NRP-1 ...

    M Kreuter, K Woelke, R Bieker, C Schliemann, M Steins, T Buechner, W E Berdel… in Leukemia (2006)

  5. No Access

    Article

    Neoadjuvante/adjuvanteTherapie in den frühen Stadien des nichtkleinzelligen Lungenkarzinoms

    In den frühen Stadien des nichtkleinzelligen Lungenkarzinoms (NSCLC) zeichnen sich derzeit die theoretisch möglichen Vorteile der neoadjuvanten Chemotherapie nur in klinischen Studien mit kleiner Patientenzahl...

    Prof. Dr. M. Thomas, H. Dienemann, D. Branscheid, N. Dickgreber, M. Steins… in Der Onkologe (2006)

  6. Article

    Open Access

    Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518)

    Even today, treatment of Stage III NSCLC still poses a serious challenge. So far, surgical resection is the treatment of choice. Patients whose tumour is not resectable or who are unfit to undergo surgery are ...

    AD Jensen, MW Münter, H Bischoff, R Haselmann, C Timke, R Krempien… in BMC Cancer (2006)

    Download PDF (219 KB) View Article

  7. No Access

    Article

    Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia

    Vascular endothelial growth factor (VEGF) and its cellular receptor VEGFR-2 have been implicated as the main endothelial pathway required for tumor neovascularization. However, the importance of the VEGF/VEGFR...

    T Padró, R Bieker, S Ruiz, M Steins, S Retzlaff, H Bürger, T Büchner, T Kessler… in Leukemia (2002)

  8. No Access

    Chapter and Conference Paper

    Evidence of Angiogenesis in Acute Myeloid Leukemia

    Angiogenesis plays a key role in the growth of solid tumors and in the development of metastases. An increased angiogenesis in bone marrow has been reported in children with acute lymphoblastic leukemia (Am J Pat...

    T. Padro, S. Ruiz, R. H. Bürger, M. Steins, R. Bieker, J. Kienast… in Acute Leukemias VIII (2001)

  9. No Access

    Article

    Hydrogen-induced changes of the structural and magnetic properties of cerium/iron multilayers

    Multilayers of Ce and Fe show a low Curie temperature and saturation magnetization below a critical thickness of the individual Fe layers where amorphous growth occurs. We have studied on a series of such mult...

    F. Klose, J. Thiele, A. Schurian, O. Schulte… in Zeitschrift für Physik B Condensed Matter (1993)